Trident Texofab Limited has issued a formal response to BSE Limited regarding inquiries about significant movement in its share price, clarifying that no undisclosed material information is affecting the stock's performance.

Company's Official Response to BSE

In a communication dated April 16, 2026, Trident Texofab addressed BSE's letter dated April 15, 2026, which sought clarification on the notable price movement of the company's shares. The response was signed by Rahul Jariwala, Company Secretary and Compliance Officer.

Regulatory Compliance and Disclosure Status

The company emphasized its commitment to regulatory compliance, stating that all material information and announcements that may impact operations or performance have been consistently disclosed. Trident Texofab confirmed adherence to the following regulatory frameworks:

• Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
• Insider trading regulations
• Timely disclosure requirements within stipulated timeframes

Market-Driven Price Movement

Triden Texofab categorically stated that the recent share price movement is purely attributable to market conditions and market-driven factors. The company clarified that it neither has control over such price movements nor possesses knowledge of the specific reasons behind the volatility.

The textile manufacturer confirmed that there is no pending information or announcement that could have a bearing on the company's share price movement, reinforcing transparency in its communication with stakeholders.

Corporate Communication Details

The official response was digitally signed by Rahul Jariwala, Company Secretary and Compliance Officer (Membership No: A70164), on April 16, 2026, at 16:47:14 +05'30'. This formal communication ensures proper documentation and regulatory compliance in addressing BSE's inquiry about the share price movement.

Trident Texofab Limited has completed its regulatory compliance requirements by submitting the mandatory Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The submission was made to BSE Limited on April 8, 2026, as part of the company's ongoing regulatory obligations.

Certificate Details and Compliance

The certificate was issued by KFin Technologies Limited, which serves as the company's Registrar and Share Transfer Agent. The document confirms that all required details of securities dematerialized and rematerialized during the quarter ended March 31, 2026, have been properly furnished to all stock exchanges where Trident Texofab's shares are listed.

Regulatory Framework

Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 mandates that registrars and share transfer agents provide quarterly certificates confirming the proper reporting of dematerialization and rematerialization activities. This regulation ensures transparency in the securities market and maintains accurate records of share transfers between physical and electronic formats.

Company Information

Triden Texofab Limited operates under CIN L17120GJ2008PLC054976 and maintains its registered office in Surat, Gujarat. The company's shares are traded on BSE with scrip code 540726. The compliance certificate submission was signed by Rahul Jariwala, Company Secretary and Compliance Officer, demonstrating the company's commitment to maintaining proper corporate governance standards.

Depository Communications

KFin Technologies Limited issued separate certificates to both major depositories in India - Central Depository Services (India) Limited (CDSL) and National Securities Depository Limited (NSDL). These communications, dated April 1, 2026, confirm that all necessary details regarding securities transactions during the quarter have been appropriately reported to the respective stock exchanges.

This regulatory submission reflects Trident Texofab's adherence to SEBI's compliance framework and its commitment to maintaining transparency in securities transactions and record-keeping processes.